Free Trial

Totally (TLY) Competitors

Totally logo
GBX 4 0.00 (0.00%)
As of 03/28/2025 12:36 PM Eastern

TLY vs. KNB, SPI, MGP, SBI, OKYO, AKR, AOR, AREC, YGEN, and POLX

Should you be buying Totally stock or one of its competitors? The main competitors of Totally include Kanabo Group (KNB), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), OKYO Pharma (OKYO), Akers Biosciences (AKR), AorTech International (AOR), Arecor Therapeutics (AREC), Yourgene Health (YGEN), and Polarean Imaging (POLX). These companies are all part of the "medical" sector.

Totally vs.

Totally (LON:TLY) and Kanabo Group (LON:KNB) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and community ranking.

51.3% of Totally shares are held by institutional investors. Comparatively, 3.8% of Kanabo Group shares are held by institutional investors. 13.3% of Totally shares are held by company insiders. Comparatively, 37.0% of Kanabo Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Totally received 131 more outperform votes than Kanabo Group when rated by MarketBeat users.

CompanyUnderperformOutperform
TotallyOutperform Votes
131
72.78%
Underperform Votes
49
27.22%
Kanabo GroupN/AN/A

In the previous week, Totally had 5 more articles in the media than Kanabo Group. MarketBeat recorded 5 mentions for Totally and 0 mentions for Kanabo Group. Totally's average media sentiment score of 1.24 beat Kanabo Group's score of 0.00 indicating that Totally is being referred to more favorably in the media.

Company Overall Sentiment
Totally Positive
Kanabo Group Neutral

Totally currently has a consensus price target of GBX 20, indicating a potential upside of 400.00%. Given Totally's stronger consensus rating and higher possible upside, equities analysts plainly believe Totally is more favorable than Kanabo Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Totally
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Kanabo Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Totally has higher revenue and earnings than Kanabo Group. Totally is trading at a lower price-to-earnings ratio than Kanabo Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Totally£133.05M0.06-£3.79M-£1.93-2.07
Kanabo Group£1.14M2.27-£8.18M-£1.29-0.32

Totally has a net margin of -2.85% compared to Kanabo Group's net margin of -717.63%. Totally's return on equity of -11.01% beat Kanabo Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Totally-2.85% -11.01% -2.42%
Kanabo Group -717.63%-121.77%-20.89%

Totally has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500. Comparatively, Kanabo Group has a beta of 3.04, indicating that its stock price is 204% more volatile than the S&P 500.

Summary

Totally beats Kanabo Group on 12 of the 17 factors compared between the two stocks.

Remove Ads
Get Totally News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLY vs. The Competition

MetricTotallyMedical Care Facilities IndustryMedical SectorLON Exchange
Market Cap£7.86M£1.50B£5.63B£2.62B
Dividend Yield13.16%3.83%5.33%4.82%
P/E Ratio-2.076.8923.60141.21
Price / Sales0.0619.61388.23284,295.48
Price / Cash9.0812.5138.1728.19
Price / Book0.231.876.894.60
Net Income-£3.79M£58.65M£3.20B£5.84B
7 Day Performance0.33%-0.46%-3.06%1.43%
1 Month PerformanceN/A-2.57%1.52%7.42%
1 Year Performance-16.67%4.07%9.37%31.20%

Totally Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLY
Totally
3.3435 of 5 stars
GBX 4
flat
GBX 20
+400.0%
-16.7%£7.86M£133.05M-2.071,668Insider Trade
News Coverage
Positive News
Gap Up
KNB
Kanabo Group
N/AGBX 0.40
-16.7%
N/A-76.6%£2.53M£1.14M-0.3120Gap Down
SPI
Spire Healthcare Group
2.5074 of 5 stars
GBX 171.80
-1.7%
GBX 314.67
+83.2%
-22.8%£689.90M£1.44B24.45420High Trading Volume
MGP
Medica Group
N/AN/AN/AN/A£259.85M£76.98M3,516.671,212
SBI
Sourcebio International
N/AN/AN/AN/A£85.31M£75.61M1,277.78194Gap Up
High Trading Volume
OKYO
OKYO Pharma
N/AN/AN/AN/A£23.24MN/A-140.007Gap Down
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32M-0.44120
AOR
AorTech International
N/AN/AN/AN/A£19.99M£539,000.00-33.383
AREC
Arecor Therapeutics
N/AGBX 47.95
-2.2%
N/A-69.8%£18.10M£6.04M-1.6910Gap Down
YGEN
Yourgene Health
N/AN/AN/AN/A£16.43M£29.67M-51.50253
POLX
Polarean Imaging
N/AGBX 1.11
-1.1%
N/A-73.5%£16.34M£5.21M-0.2928
Remove Ads

Related Companies and Tools


This page (LON:TLY) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners